Asia Pacific Latent Tuberculosis Infection Detection Market Size & Outlook

The latent tuberculosis infection detection market in Asia Pacific is expected to reach a projected revenue of US$ 1,243.1 million by 2030. A compound annual growth rate of 7.5% is expected of Asia Pacific latent tuberculosis infection detection market from 2024 to 2030.
Revenue, 2023 (US$M)
$750.2
Forecast, 2030 (US$M)
$1,243.1
CAGR, 2024 - 2030
7.5%
Report Coverage
Asia Pacific

Asia Pacific latent tuberculosis infection detection market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific latent tuberculosis infection detection market highlights

  • The Asia Pacific latent tuberculosis infection detection market generated a revenue of USD 750.2 million in 2023.
  • The market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
  • In terms of segment, other brands was the largest revenue generating brand in 2023.
  • QFT-Plus (QuantiFERON-TB Gold Plus) is the most lucrative brand segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 750.2 million
Market revenue in 2030USD 1,243.1 million
Growth rate7.5% (CAGR from 2023 to 2030)
Largest segmentOther brands
Fastest growing segmentQFT-Plus (QuantiFERON-TB Gold Plus)
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationQFT-Plus (QuantiFERON-TB Gold Plus), Other brands
Key market players worldwideBioMerieux SA, Roche Holding AG, Abbott Laboratories, Sanofi SA, PerkinElmer, Becton Dickinson & Co, Serum Institute of India Pvt. Ltd., Lionex Diagnostics & Therapeutics


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 42.8% of the global latent tuberculosis infection detection market in 2023.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,243.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Latent Tuberculosis Infection Detection Market Companies

Name Profile # Employees HQ Website

Asia Pacific latent tuberculosis infection detection market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to latent tuberculosis infection detection market will help companies and investors design strategic landscapes.


Other brands was the largest segment with a revenue share of 77.42% in 2023. Horizon Databook has segmented the Asia Pacific latent tuberculosis infection detection market based on qft-plus (quantiferon-tb gold plus), other brands covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Asia Pacific latent tuberculosis infection detection market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific latent tuberculosis infection detection market databook

  • Our clientele includes a mix of latent tuberculosis infection detection market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific latent tuberculosis infection detection market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific latent tuberculosis infection detection market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific latent tuberculosis infection detection market size, by country, 2018-2030 (US$M)

Asia Pacific Latent Tuberculosis Infection Detection Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific latent tuberculosis infection detection market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more